Stock Research: DiaSorin

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

DiaSorin

MIL:DIA IT0003492391
30
  • Value
    88
  • Growth
    23
  • Safety
    Safety
    73
  • Combined
    61
  • Sentiment
    15
  • 360° View
    360° View
    30
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DiaSorin SpA develops, produces, and commercializes reagent kits for in vitro diagnostics. The company operates in the healthcare industry, specializing in infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company operates in the Immunodiagnostics and Molecular Diagnostics markets. In the last fiscal year, the company had a market cap of $5,841 million, profits of $809 million, revenue of $1,227 million, and 3271 employees.

more

ANALYSIS: With an Obermatt 360° View of 30 (better than 30% compared with alternatives), overall professional sentiment and financial characteristics for the stock DiaSorin are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for DiaSorin. The consolidated Value Rank has an attractive rank of 88, which means that the share price of DiaSorin is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 88% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 73. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 15. Professional investors are more confident in 85% other stocks. The consolidated Growth Rank also has a low rank of 23, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 77 of its competitors have better growth. ...read more

more
Index
MIB
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 32 23 34
Growth
23 88 21 7
Safety
Safety
73 48 50 98
Sentiment
15 60 10 90
360° View
360° View
30 80 6 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
21 13 13 19
Opinions Change
44 50 10 64
Pro Holdings
n/a 73 31 90
Market Pulse
39 75 65 89
Sentiment
15 60 10 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 32 23 34
Growth
23 88 21 7
Safety Safety
73 48 50 98
Combined
61 75 6 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
61 26 27 27
Price vs. Earnings (P/E)
60 34 33 31
Price vs. Book (P/B)
71 40 37 37
Dividend Yield
77 47 39 37
Value
88 32 23 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
40 73 12 12
Profit Growth
67 83 12 54
Capital Growth
23 76 100 27
Stock Returns
8 56 18 32
Growth
23 88 21 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
47 20 22 92
Refinancing
88 53 59 71
Liquidity
64 61 53 92
Safety Safety
73 48 50 98

Similar Stocks

Discover high‑ranked alternatives to DiaSorin and broaden your portfolio horizons.

Azimut

MIL:AZM
Country: Italy
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Hera

MIL:HER
Country: Italy
Industry: Multi-Utilities
Size: X-Large
Full Stock Analysis

Poste Italiane

MIL:PST
Country: Italy
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: